Global Health & Biotech Archives | Page 96 of 292 | Be Korea-savvy

Archive by category Global Health & Biotech

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]

Malaysia Showcases Its World-Class Healthcare Offerings at Oman Health 2023

Malaysia Showcases Its World-Class Healthcare Offerings at Oman Health 2023

Malaysia Healthcare offers exclusive packages from leading private hospitals in the areas of fertility, oncology, orthopaedics, and premium wellness MUSCAT, Oman, Sept. 18, 2023 (Korea Bizwire) – Malaysia Healthcare is showcasing its world-class healthcare offerings to Omanis, at the annual Oman Health Exhibition and Conference (OHEC), held at the Oman Convention & Exhibition Centre in [...]

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

COSTA MESA, Calif., Sept. 18, 2023 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors. Dr. Kaplan served as the Executive Vice President and President, Research & Development and Global [...]

Purdue Researcher Awarded $1.3 Million for Malaria Drug Trials in Southeast Asia and Africa

Purdue Researcher Awarded $1.3 Million for Malaria Drug Trials in Southeast Asia and Africa

Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced WEST LAFAYETTE, Ind., Sept. 15, 2023 (Korea Bizwire) – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open Philanthropy has awarded [...]

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept. 13, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate Bioscience, has received IND clearance from the FDA and has dosed the first participant with [...]

Philips Extends Its Mobile C-arm Range with Zenition 30, Alleviating Staff Shortages by Empowering Surgeons with Greater Personalization and Control

Philips Extends Its Mobile C-arm Range with Zenition 30, Alleviating Staff Shortages by Empowering Surgeons with Greater Personalization and Control

Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips’ new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures   Advanced imaging algorithms contribute to outstanding image quality and dose efficiency Amsterdam, the Netherlands, September 13, 2023 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a [...]

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Mont-Saint-Guibert, Belgium, Sept. 13 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which takes place September 26 – 28, 2023 [...]

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound Promoting Anti-Cancer Immune Responses

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound Promoting Anti-Cancer Immune Responses

SPRING, Texas, Sept. 12, 2023 (Korea Bizwire) – Io Therapeutics, Inc., announced today the publication in Scientific Reports – Nature Publishing Group, of results from studies done with the company’s novel anti-cancer compound IRX4647, an agonist of the retinoic acid nuclear receptor gamma, discovered in the company’s oncology drug program. The paper, titled “A novel retinoic acid [...]

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

BOSTON, Sept. 11, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies. Novotech is collaborating with Endpoints News to jointly host this webinar. The webinar will examine how China’s focus on cutting-edge innovations and [...]

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened viral shedding duration in participants with confirmed influenza infection MELBOURNE, Australia and MILAN, Italy, Sept. 11, 2023 (KOREA BIZWIRE) – ENA Respiratory, a clinical-stage pharmaceutical company, announced positive data from the Phase 2a flu challenge study of INNA-051, a first-in-class, broad-spectrum, [...]